Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | glutaminase | 0.0297 | 0.3511 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0051 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.002 | 0.0051 | 0.0093 |
Plasmodium vivax | macrophage migration inhibitory factor, putative | 0.0347 | 0.4143 | 0.5 |
Leishmania major | macrophage migration inhibitory factor-like protein | 0.0347 | 0.4143 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0051 | 0.5 |
Trichomonas vaginalis | macrophage migration inhibitory factor, mif, putative | 0.0347 | 0.4143 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0347 | 0.4143 | 1 |
Schistosoma mansoni | intermediate filament proteins | 0.0029 | 0.017 | 0.0343 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0242 | 0.283 | 0.2793 |
Echinococcus granulosus | geminin | 0.0171 | 0.1935 | 0.6778 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0029 | 0.017 | 0.031 |
Loa Loa (eye worm) | macrophage migration inhibitory factor | 0.0347 | 0.4143 | 0.7571 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.002 | 0.0051 | 0.0093 |
Schistosoma mansoni | hypothetical protein | 0.0171 | 0.1935 | 0.5444 |
Trypanosoma brucei | unspecified product | 0.002 | 0.0051 | 0.5 |
Echinococcus multilocularis | Protein lozenge | 0.0057 | 0.0515 | 0.0466 |
Loa Loa (eye worm) | runx1 | 0.0057 | 0.0515 | 0.0941 |
Echinococcus multilocularis | musashi | 0.0029 | 0.017 | 0.0119 |
Schistosoma mansoni | glutaminase | 0.0297 | 0.3511 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.002 | 0.0051 | 0.5 |
Trichomonas vaginalis | glutaminase, putative | 0.0297 | 0.3511 | 0.8456 |
Loa Loa (eye worm) | macrophage migration inhibitory factor 2 | 0.0148 | 0.1655 | 0.3024 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0051 | 0.5 |
Onchocerca volvulus | 0.0049 | 0.0421 | 0.0474 | |
Schistosoma mansoni | lozenge | 0.0057 | 0.0515 | 0.1341 |
Schistosoma mansoni | lamin | 0.0029 | 0.017 | 0.0343 |
Echinococcus granulosus | intermediate filament protein | 0.0029 | 0.017 | 0.0427 |
Leishmania major | macrophage migration inhibitory factor-like protein | 0.0347 | 0.4143 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0051 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0171 | 0.1935 | 0.5444 |
Echinococcus multilocularis | lamin dm0 | 0.0029 | 0.017 | 0.0119 |
Schistosoma mansoni | survival motor neuron protein | 0.0049 | 0.0421 | 0.107 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0051 | 0.5 |
Brugia malayi | Bm-MIF-1, identical | 0.0347 | 0.4143 | 0.7571 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.002 | 0.0051 | 0.0093 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0051 | 0.5 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.002 | 0.0051 | 0.5 |
Entamoeba histolytica | macrophage migration inhibitory factor-like protein | 0.0347 | 0.4143 | 1 |
Loa Loa (eye worm) | glutaminase | 0.0297 | 0.3511 | 0.6416 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0051 | 0.5 |
Brugia malayi | hypothetical protein | 0.0454 | 0.5472 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.002 | 0.0051 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0051 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0051 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0454 | 0.5472 | 1 |
Echinococcus granulosus | lamin | 0.0029 | 0.017 | 0.0427 |
Loa Loa (eye worm) | hypothetical protein | 0.0454 | 0.5472 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0051 | 0.5 |
Brugia malayi | glutaminase DH11.1 | 0.0297 | 0.3511 | 0.6416 |
Echinococcus multilocularis | lamin | 0.0029 | 0.017 | 0.0119 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.0421 | 0.107 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0051 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0051 | 0.0093 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0051 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0051 | 0.5 |
Giardia lamblia | Macrophage migration inhibitory factor | 0.0347 | 0.4143 | 1 |
Onchocerca volvulus | 0.0454 | 0.5472 | 1 | |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0051 | 0.5 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.002 | 0.0051 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0242 | 0.283 | 0.5172 |
Echinococcus granulosus | lamin dm0 | 0.0029 | 0.017 | 0.0427 |
Schistosoma mansoni | lamin | 0.0029 | 0.017 | 0.0343 |
Brugia malayi | hypothetical protein | 0.0242 | 0.283 | 0.5172 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0051 | 0.5 |
Echinococcus multilocularis | geminin | 0.0171 | 0.1935 | 0.1893 |
Plasmodium falciparum | macrophage migration inhibitory factor | 0.0347 | 0.4143 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.017 | 0.031 |
Loa Loa (eye worm) | macrophage migration inhibitory factor 2 | 0.0148 | 0.1655 | 0.3024 |
Brugia malayi | intermediate filament protein | 0.0029 | 0.017 | 0.031 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0051 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0051 | 0.5 |
Loa Loa (eye worm) | intermediate filament protein | 0.0029 | 0.017 | 0.031 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0242 | 0.283 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0163 | 0.0298 |
Loa Loa (eye worm) | glutaminase 2 | 0.0297 | 0.3511 | 0.6416 |
Toxoplasma gondii | macrophage migration inhibitory factor, putative | 0.0347 | 0.4143 | 0.5 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0029 | 0.017 | 0.031 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0049 | 0.0421 | 0.077 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.